These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 6423929)

  • 1. Long-term calcitonin therapy in postmenopausal osteoporosis.
    Gruber HE; Ivey JL; Baylink DJ; Matthews M; Nelp WB; Sisom K; Chesnut CH
    Metabolism; 1984 Apr; 33(4):295-303. PubMed ID: 6423929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coherence treatment of postmenopausal osteoporosis with growth hormone and calcitonin.
    Aloia JF; Vaswani A; Meunier PJ; Edouard CM; Arlot ME; Yeh JK; Cohn SH
    Calcif Tissue Int; 1987 May; 40(5):253-9. PubMed ID: 2981045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of intermittent administration of 200 IU intranasal salmon calcitonin and low doses of 1alpha(OH) vitamin D3 on bone mineral density of the lumbar spine and hip region and biochemical bone markers in women with postmenopausal osteoporosis: a pilot study.
    Kaskani E; Lyritis GP; Kosmidis C; Galanos A; Andypas G; Chorianopoulos K; Giagiosis A; Iliadou K; Karagianis A; Katsimichas K; Koskinas A; Matsouka K
    Clin Rheumatol; 2005 Jun; 24(3):232-8. PubMed ID: 15647969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of salmon calcitonin in postmenopausal osteoporosis: a controlled double-blind clinical study.
    Mazzuoli GF; Passeri M; Gennari C; Minisola S; Antonelli R; Valtorta C; Palummeri E; Cervellin GF; Gonnelli S; Francini G
    Calcif Tissue Int; 1986 Jan; 38(1):3-8. PubMed ID: 3079649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms underlying the effects of phosphate and calcitonin on bone histology in postmenopausal osteoporosis.
    Marie PJ; Caulin F
    Bone; 1986; 7(1):17-22. PubMed ID: 3964494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stanozolol in postmenopausal osteoporosis: therapeutic efficacy and possible mechanisms of action.
    Chesnut CH; Ivey JL; Gruber HE; Matthews M; Nelp WB; Sisom K; Baylink DJ
    Metabolism; 1983 Jun; 32(6):571-80. PubMed ID: 6341772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone turnover in postmenopausal osteoporosis. Effect of calcitonin treatment.
    Civitelli R; Gonnelli S; Zacchei F; Bigazzi S; Vattimo A; Avioli LV; Gennari C
    J Clin Invest; 1988 Oct; 82(4):1268-74. PubMed ID: 3262626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calcium and salmon calcitonin in treatment of osteoporosis.
    Jowsey J; Riggs BL; Kelly PJ; Hoffman DL
    J Clin Endocrinol Metab; 1978 Sep; 47(3):633-9. PubMed ID: 263316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deficient calcitonin response to calcium stimulation in postmenopausal osteoporosis?
    Taggart HM; Chesnut CH; Ivey JL; Baylink DJ; Sisom K; Huber MB; Roos BA
    Lancet; 1982 Feb; 1(8270):475-8. PubMed ID: 6121141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Osteoblast numbers after calcitonin therapy: a retrospective study of paired biopsies obtained during long-term calcitonin therapy in postmenopausal osteoporosis.
    Gruber HE; Grigsby J; Chesnut Ill CH
    Calcif Tissue Int; 2000 Jan; 66(1):29-34. PubMed ID: 10602841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and efficacy of a novel salmon calcitonin (sCT) technology-based oral formulation in healthy postmenopausal women: acute and 3-month effects on biomarkers of bone turnover.
    Tankó LB; Bagger YZ; Alexandersen P; Devogelaer JP; Reginster JY; Chick R; Olson M; Benmammar H; Mindeholm L; Azria M; Christiansen C
    J Bone Miner Res; 2004 Sep; 19(9):1531-8. PubMed ID: 15312255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of salmon calcitonin on trabecular microarchitecture as determined by magnetic resonance imaging: results from the QUEST study.
    Chesnut CH; Majumdar S; Newitt DC; Shields A; Van Pelt J; Laschansky E; Azria M; Kriegman A; Olson M; Eriksen EF; Mindeholm L
    J Bone Miner Res; 2005 Sep; 20(9):1548-61. PubMed ID: 16059627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Behavior of urinary excretion of cyclic AMP in post-menopausal osteoporosis during therapy with salmon calcitonin].
    Nuti R; Galli M; Righi GA; Turchetti V; Campagna MS; Franci B
    Minerva Med; 1982 May; 73(19):1283-9. PubMed ID: 6281691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Basal plasma immunoreactive calcitonin in postmenopausal osteoporosis.
    Chesnut CH; Baylink DJ; Sisom K; Nelp WB; Roos BA
    Metabolism; 1980 Jun; 29(6):559-62. PubMed ID: 7382823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A phase 3 trial of the efficacy and safety of oral recombinant calcitonin: the Oral Calcitonin in Postmenopausal Osteoporosis (ORACAL) trial.
    Binkley N; Bolognese M; Sidorowicz-Bialynicka A; Vally T; Trout R; Miller C; Buben CE; Gilligan JP; Krause DS;
    J Bone Miner Res; 2012 Aug; 27(8):1821-9. PubMed ID: 22437792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of skeletal calcium deficiency in postmenopausal osteoporosis.
    Burnell JM; Baylink DJ; Chesnut CH; Teubner EJ
    Calcif Tissue Int; 1986 Apr; 38(4):187-92. PubMed ID: 3085896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effects of salmon calcitonin in treatment of osteoporosis in patients undergoing dialysis].
    Wang SX; Li H
    Zhonghua Yi Xue Za Zhi; 2008 Feb; 88(6):387-90. PubMed ID: 18581891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized, double-blind, multicenter, placebo-controlled study to evaluate the efficacy and safety of oral salmon calcitonin in the treatment of osteoporosis in postmenopausal women taking calcium and vitamin D.
    Henriksen K; Byrjalsen I; Andersen JR; Bihlet AR; Russo LA; Alexandersen P; Valter I; Qvist P; Lau E; Riis BJ; Christiansen C; Karsdal MA;
    Bone; 2016 Oct; 91():122-9. PubMed ID: 27462009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of calcitonin on biochemical markers and zinc excretion in postmenopausal osteoporosis.
    Colpan L; Gur A; Cevik R; Nas K; Sarac AJ
    Maturitas; 2005 Jul; 51(3):246-53. PubMed ID: 15978968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of cyclic and continuous calcitonin regimens in the treatment of postmenopausal osteoporosis.
    Tekeoğlu I; Adak B; Budancamanak M; Demirel A; Ediz L
    Rheumatol Int; 2005 Dec; 26(2):157-61. PubMed ID: 15660234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.